Maternal Innate Immune Reprogramming After Complicated Pregnancy
- PMID: 39119763
- DOI: 10.1111/aji.13908
Maternal Innate Immune Reprogramming After Complicated Pregnancy
Abstract
Problem: Preeclampsia (PE) and fetal growth restriction (FGR) are often associated with maternal inflammation and an increased risk of cardiovascular and metabolic disease in the affected mothers. The mechanism responsible for this increased risk of subsequent disease may involve reprogramming of innate immune cells, characterized by epigenetic modifications.
Method of study: Circulating monocytes from women with PE, FGR, or uncomplicated pregnancies (control) were isolated before labor. Cytokine release from monocytes following exposure to lipopolysaccharide (LPS) and the presence of lysine 4-trimethylated histone 3 (H3K4me3) within TNF promoter sequences were evaluated. Single-cell transcriptomic profiles of circulating monocytes from women with PE or uncomplicated pregnancies were assessed.
Results: Monocytes from women with PE or FGR exhibited increased IL-10 secretion and decreased IL-1β and GM-CSF secretion in response to LPS. While TNFα secretion was not significantly different in cultures of control monocytes versus those from complicated pregnancies with or without LPS exposure, monocytes from complicated pregnancies had significantly decreased levels of H3K4me3 associated with TNF promoter sequences. Cluster quantification and pathway analysis of differentially expressed genes revealed an increased proportion of anti-inflammatory myeloid cells and a lower proportion of inflammatory non-classical monocytes among the circulating monocyte population in women with PE.
Conclusions: Monocytes from women with PE and FGR exhibit an immune tolerance phenotype before initiation of labor. Further investigation is required to determine whether this tolerogenic phenotype persists after the affected pregnancy and contributes to increased risk of subsequent disease.
Keywords: epigenomics; fetal growth restriction; monocyte; preeclampsia; single‐cell RNA sequence analysis; tolerance; trained immunity.
© 2024 The Author(s). American Journal of Reproductive Immunology published by John Wiley & Sons Ltd.
References
-
- J. H. Kristensen, S. Basit, J. Wohlfahrt, M. B. Damholt, and H. A. Boyd, “Pre‐Eclampsia and Risk of Later Kidney Disease: Nationwide Cohort Study,” BMJ 365 (2019): l1516, https://doi.org/10.1136/bmj.l1516.
-
- H. U. Irgens, J. M. Roberts, L. Reisæter, L. M. Irgens, and R. T. Lie, “Long Term Mortality of Mothers and Fathers After Pre‐Eclampsia: Population Based Cohort Study,” BMJ 323, no. 7323 (2001): 1213, https://doi.org/10.1136/bmj.323.7323.1213.
-
- T. Pittara, A. Vyrides, D. Lamnisos, and K. Giannakou, “Pre‐Eclampsia and Long‐Term Health Outcomes for Mother and Infant: An Umbrella Review,” BJOG: An International Journal of Obstetrics & Gynaecology 128, no. 9 (2021): 1421–1430, https://doi.org/10.1111/1471‐0528.16683.
-
- D. J. P. Barker, “Adult Consequences of Fetal Growth Restriction,” Clinical Obstetrics and Gynecology 49, no. 2 (2006): 270–283.
-
- M. Venetkoski, J. Joensuu, M. Gissler, O. Ylikorkala, T. S. Mikkola, and H. Savolainen‐Peltonen, “Pre‐Eclampsia and Cardiovascular Risk: A Long‐Term Nationwide Cohort Study on Over 120 000 Finnish Women,” BMJ Open 12, no. 12 (2022): e064736, https://doi.org/10.1136/bmjopen‐2022‐064736.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous